Here, we examine mTORC1 regulation of GSK3β nuclear localization and function. To 143 do so, we use pharmacological and other approaches to manipulate mitogenic or metabolic 144 signals and examine GSK3β localization to various endomembrane compartments and nucleus as 145 well as GSK3β-dependent functions associated with nuclear GSK3β. We find a novel regulatory 146 axis sensing mitogenic signals, metabolic cues and membrane traffic at the late 147 endosome/lysosome that modulates GSK3β nuclear localization and function. 148
Results

150
The PI3K-Akt signaling pathway controls GSK3β nucleocytoplasmic shuttling and thus 151 access of GSK3β to nuclear targets either directly or via activation of the downstream kinase 152 mTORC1. mTORC1 integrates both mitogenic (PI3K-Akt) and metabolic cues, and is localized 153 to the lysosome once activated. Using a variety of strategies to manipulate mitogenic and 154 metabolic signals converging on mTORC1 and lysosomal membrane traffic, we examined how 155 mTORC1 regulates GSK3β nuclear access and function. 156 157 mTORC1 controls GSK3β nuclear localization and c-myc expression 158
159
To determine whether mTORC1 regulates GSK3β localization and function downstream of 160 PI3K/Akt, we first examined the effect of the mTORC1 inhibitor rapamycin on c-myc 161 expression. Treatment of ARPE-19 cells (RPE henceforth) with 1 μ g/mL rapamycin caused a 162 time-dependent decrease in c-myc expression, reaching 57 ± 4.8% after 2 hours of rapamycin 163 treatment (n = 6, p < 0.05, Fig. 1A) . Importantly, co-treatment with 10 μ M of the GSK3β kinase 164 inhibitor CHIR99021 blunted the decrease in c-myc expression elicited by rapamycin treatment 165 (Fig. 1A) . Consistent with this result, rapamycin treatment also elicited a reduction in expression 166 of the transcription factor snail, an effect also blunted by co-treatment with CHIR 99021 (Fig.  167   1B) . 168 We next used siRNA gene silencing of GSK3β, which resulted in a 91 ± 4.7% reduction of 169 GSK3β protein levels (n = 3, p < 0.05, Fig. S1A ). While RPE cells also express the paralog 170 GSK3α, silencing of GSK3β was specific and did not impact expression of GSK3α (Fig. S1B) . 171 Cells subjected to silencing of GSK3β exhibited no change in c-myc upon inhibition of 172 sequential signals in the PI3K-Akt-mTORC1 axis, achieved by treatment with either LY294002, 173
Akti-1/2, or rapamycin, respectively (Fig. 1C) . In contrast, each inhibitor effectively reduced c-174 myc expression in cells subjected to non-targeting (control) siRNA treatment (Fig. 1C) . Taken  175 together, these results indicate that PI3K-Akt signals converge on mTORC1 to enhance c-myc 176 levels in a manner that requires the regulation of GSK3β. 177
To determine how PI3K-Akt-mTORC1 signals control c-myc expression in a GSK3β-178 dependent manner, we examined the localization and levels of endogenous GSK3β and c-myc.active PI3K-Akt-mTORC1 axis, GSK3β primarily localizes within the cytosol and appears 181 mostly excluded from the nucleus ( Fig. 2A) . We confirmed the specificity of detection of 182 endogenous GSK3β by immunofluorescence microscopy following GSK3β silencing (Fig. S1C) . 183
In contrast, and as expected (Abrams et al., 1982; Hann et al., 1983; Smith et al., 2004) , c-myc 184 localizes virtually entirely within the nucleus under these conditions ( Fig. 2A) . Thus, under 185 conditions in which mTORC1 is active, GSK3β and c-myc are compartmentalized separately 186 within the cytosol and nucleus, respectively. 187
We next determined how PI3K-Akt-mTORC1 signaling regulates GSK3β localization. 188
Treatment of RPE cells with either LY294002, Akti-1/2, or rapamycin to perturb PI3K, Akt or 189 mTORC1, respectively resulted in robust and significant (n = 3, p < 0.05) increase in nuclear 190 GSK3β, measured by the ratio of nuclear to cytosolic mean fluorescence intensities of GSK3β 191 which we term the GSK3β nuclear localization index (Fig. 2B) . Importantly, the effect of 192 rapamycin treatment on GSK3β nuclear translocation and snail protein levels was also observed 193 in MDA-MB-231 breast cancer cells (Fig. S1D-E) , demonstrating that the mTORC1-dependent 194 control of GSK3β is not unique to RPE cells. Furthermore, inhibition of the PI3K-Akt-mTORC1 195 axis also resulted in robust nuclear localization of GSK3α (Fig. S1E) , a paralog of GSK3β with 196 highly similar kinase domains but unique terminal motifs (Cormier and Woodgett, 2017; 197 Woodgett, 1990 ). These results indicate that PI3K-Akt signals act via control of mTORC1 to 198 regulate GSK3β nuclear localization, as well as that of GSK3α. 199 To test the importance of Ran in mTORC1-dependent GSK3β nuclear translocation, we 200 examined the impact of Ran GTP-binding mutants on GSK3β localization. We expressed wild-201 type (WT) Ran or one of two Ran mutants, Ran T24N and G19V, which are constitutively GDP-202 or GTP-bound, respectively (Carey et al., 1996) . Cells expressing WT Ran exhibited little 203 nuclear GSK3β in the control condition, but a robust localization of GSK3β in the nucleus was 204 observed upon treatment with rapamycin (Fig. 3 , upper panels, and quantification, lower panel). 205
In contrast, cells expressing Ran T24N exhibited nuclear GSK3β in both control and rapamycin-206 treated conditions (Fig. 3) , consistent with Ran-GDP acting to facilitate nuclear import (Carey et 207 al., 1996) . Further, cells expressing Ran G19V exhibited mostly cytosolic GSK3β in both control 208 and rapamycin-treated conditions, consistent with this mutant blocking Ran-dependent nuclear 209 import (Fig. 3) . These results indicate that GSK3β undergoes Ran-dependent nucleocytoplasmic 210 shuttling and Ran-dependent nuclear import that is regulated by mTORC1. 211
212
Metabolic cues regulate GSK3β nuclear localization via mTORC1 213 214 As mTORC1 is regulated by both mitogenic (PI3K-Akt) signals as well as metabolic cues, 215
we next examined how each of these signals contributes to the control of GSK3β nuclear 216 localization. AMPK is activated via ATP insufficiency, and negatively regulates mTORC1 217 signaling through phosphorylation and activation of TSC2 (Inoki et al., 2006; Shaw et al., 2004) . 218
Consistent with the effects of mTORC1 inhibition by rapamycin, treatment with the AMPK 219 activator A769662 resulted in robust GSK3β nuclear localization (Fig. 4A) . Importantly, AMPK 220 and mTORC1 exhibit reciprocal negative regulation (Inoki et al., 2012) . As such, GSK3β nuclear 221 localization could conceivably be the direct result of loss of mTORC1 signals, or an increase in 222 AMPK activation, both of which would be expected to occur upon treatment with either 223 rapamycin or A769662. To dissect a role for mTORC1 versus AMPK in control of GSK3β 224 nuclear localization, we used the AMPK inhibitor compound C (Ross et al., 2015). Cells treated 225 with compound C exhibited a rapamycin-dependent increase in GSK3β nuclear localization 226 comparable to that observed in cells treated with rapamycin but not compound C (Fig. 4A) . This 227
indicates that AMPK activity is dispensable for GSK3β nuclear localization induced by 228 mTORC1 inhibition. As GSK3β forms a complex with AMPK (Suzuki et al., 2013), we also 229 tested whether AMPK may have a kinase-independent, structural role in regulation of GSK3β. 230
However, silencing of AMPK did not impact GSK3β nuclear localization (Fig. S2) . Collectively, 231 these results indicate that while AMPK activation also triggers an accumulation of nuclear 232 GSK3β, this occurs as a result of AMPK-dependent inhibition of mTORC1 signals, and not as a 233 result of direct action of AMPK on GSK3β nuclear localization. Cells treated with Concanamycin A exhibited a significant enhancement of nuclear GSK3β 238 relative to control (Fig. 4B) . Consistent with this result, amino acid deprivation achieved via 239 treatment of cells in amino acid depleted media (EBSS) also mimicked the effect of rapamycin9 treatment in RPE (Fig. 4C) as well as MDA-MB-231 (Fig. S1C) cells. These results indicate that 241 amino acid sensing by mTORC1 contributes to the regulation of GSK3β nuclear localization. 242 mTORC1 inhibition also leads to induction of autophagy (Jung et al., 2009 ). We therefore 243 tested whether autophagy is required for GSK3β nuclear localization upon mTORC1 inhibition 244 with rapamycin. To inhibit autophagy induction, we treated cells siRNA targeting endogenous 245 ULK (Saric et al., 2016), which resulted in a robust 77% ± 6.2 reduction of ULK expression (n = 246 3, p < 0.05, Fig. S3A ). Cells treated with siRNA to silence ULK1 exhibited cytosolic GSK3β, 247 which relocalized to the nucleus upon rapamycin treatment in a manner indistinguishable from 248 cells treated with non-targeting siRNA (Fig. S3B) . As autophagy induction has also been 249 reported to lead to c-myc degradation (Cianfanelli et al., 2014), we also tested the effect of 250 ULK1 silencing on rapamycin-induced c-myc expression. Surprisingly, silencing of ULK1 on its 251 own reduced c-myc expression (Fig. 3C) . Moreover, and in contrast to the findings of a previous 252 study (Cianfanelli et al., 2014), impairment of autophagy induction by ULK1 silencing did not 253 prevent the rapamycin-induced reduction in c-myc expression (Fig. S3C) . Thus, GSK3β nuclear 254 translocation and c-myc degradation observed upon mTORC1 inhibition are largely independent 255 of autophagy induction. Instead, c-myc degradation upon mTORC1 inhibition is mediated by 256 regulation of GSK3β nuclear localization and function. 257
258
Control of GSK3β nuclear localization does not require GSK3β S9 phosphorylation 259 260 Akt phosphorylates GSK3β on S9, which negatively regulates GSK3β kinase activity 261 towards certain substrates. We next examined how GSK3β phosphorylation may contribute to 262 control of GSK3β nuclear localization by mTORC1. As expected, cells treated with LY294002 263 or Akti-1/2 exhibited significant reductions in GSK3β S9 phosphorylation by 80 ± 0.8 % and 60 264 ± 6.8% respectively (n = 3, p < 0.05, Fig. 5A ). In contrast, cells treated with rapamycin exhibited 265 no change in GSK3β S9 phosphorylation compared to control (Fig. 5A) . These results uncouple 266 S9 phosphorylation from control of GSK3β nuclear localization. To directly probe the 267 contribution of GSK3β S9 phosphorylation to mTORC1-dependent GSK3β nuclear localization, 268
we studied the subcellular localization of GSK3β S9A. Under basal conditions, GSK3β S9A 269 remains cytosolic, while treatment with the Akt inhibitor Akti-1/2 resulted in nuclear localization 270 of GSK3β S9A, as seen with GSK3β WT (Fig. 5B) .
Collectively, these results indicate that regulation of GSK3β S9 phosphorylation does not 277 contribute to control of GSK3β nuclear localization by PI3K-Akt-mTORC1 signals. GSK3β is indeed localized to lysosomes concomitantly to GSK3β recruitment to other 286 endomembrane compartments, we systematically examined the localization of endogenous 287
GSK3β relative to APPL1 and EEA1 early endosomes, and to lysosomes demarked by LAMP1. 288
We observed punctate distribution of endogenous GSK3β within the cytoplasm, with some 289 visible overlap with each of APPL1, EEA1 and LAMP1 ( Fig. 6A-C , left panels). To determine if 290 the overlap observed between GSK3β and each marker was specific, we used quantification by 291
Manders' coefficient to compare overlap between real pairs of image channels, as well as 292 between pairs of images with scrambled channel spatial position. This revealed specific GSK3β 293 recruitment to each membrane compartment ( Fig. 6A-C) . We performed a similar colocalization 294 analysis of the image data using Pearson's coefficient and obtained similar results (Fig. S4B) . 295
This indicates that GSK3β indeed exhibits partial yet specific localization to several distinct 296 endomembrane compartments, including APPL1 and EEA1 early endosomes, and late 297 endosomes/lysosomes demarked by LAMP1. 298
To further examine how GSK3β may localize to lysosomes, we employed structured 299 illumination microscopy (SIM). Using this method, we were able to resolve the limiting 300 membrane of lysosomes demarked by LAMP1 fluorescence staining (Fig. 6D) . Importantly, 301
GSK3β fluorescence staining was readily observed in punctate structures, in part associated withthe limiting membrane of the lysosome. These results indicate that a subset of GSK3β in the 303 cytoplasm exhibits association with the lysosome, either restricted to sub-domains of the 304 lysosomal surface (Kaushik et al., 2006) ( Fig. 6C-D) to or near the lysosome, we next sought to determine the role of late 312 endosome/lysosome membrane traffic to mTORC1-dependent control of GSK3β nuclear 313 localization. To do so, we used a Rab7 mutant that is constitutively GDP-bound (T22N), which 314 disrupts membrane traffic at the late endosome/lysosome (Choudhury et al., 2002). Cells 315 expressing Rab7 T22N exhibited a significant increase in nuclear GSK3β, even in the absence of 316 rapamycin treatment, compared to cells expressing Rab7 WT (Fig. 7A) . Furthermore, cells 317 expressing Rab7 T22N exhibited a depletion of GSK3β from lysosomes, observed by overlap of 318 endogenous GSK3β and LAMP1, quantified by Manders' coefficient ( Fig. S4C) . In contrast to 319 the nuclear accumulation of GSK3β in cells expressing Rab7 T22N, silencing of APPL1 to 320 disrupt early endosome membrane traffic did not impact GSK3β nuclear localization (Fig. S4D) . 321 These results indicate that membrane traffic at the late endosome/lysosome may be important to 322 organize mTORC1 signals leading to control of GSK3β nuclear localization. 323
In order to determine the consequence of Rab7-dependent control of GSK3β nuclear 324 localization, we examined the effect of expression of Rab7 T22N on GSK3β-dependent c-myc 325 expression levels. Cells expressing Rab7 T22N exhibited a stark reduction in c-myc expression 326 relative to cells expressing Rab7 WT (Fig. 7B) . Importantly, treatment of cells expressing Rab7 327 T22N with the GSK3β inhibitor CHIR 99021 restored c-myc expression levels to that observed 328 in cells expressing Rab7 WT (Fig. 7B) . Taken together, these results indicate that control of 329
GSK3β nuclear localization requires Rab7-dependent late endosome/lysosomal membrane 330 traffic, reflecting perhaps the role of lysosomes as platform for mTORC1 signaling required to 331 negatively regulate GSK3β nuclear translocation. 332 conditions that reduce mTORC1 activity result in increased nuclear localization of GSK3β, and 336 increased GSK3β-dependent degradation of nuclear substrates such as c-myc and snail. 337
Furthermore, GSK3β was partly but specifically localized to the surface of late 338 endosomes/lysosomes, and perturbation of membrane traffic at the late endosomes/lysosomes 339 disrupted GSK3β nucleocytoplasmic shuttling and regulation of c-myc expression. 340 341
Localization of GSK3β within multiple membrane compartments within the cytoplasm 342 343
Separate studies have reported that GSK3β may localize to a number of distinct cellular 344 compartments, including endomembranes, mitochondria and the nucleus (reviewed by (Beurel et 345 al., 2015)). By a systematic, unbiased approach, we find that endogenous GSK3β localizes to 346 several distinct endomembrane compartments, including APPL1 endosomes, EEA1-positive 347 early endosomes and LAMP1-positive late endosomes/lysosomes (Fig. 6) . In each case, the 348 overlap of GSK3β immunofluorescence signal and that of each compartment marker is clearly 349 limited and partial, with substantial proportions of each signal not exhibiting overlap (Fig. 6A-350 C). However, systematic and unbiased analysis of colocalization performed by Manders' (Fig.  351 
6A-C) or Pearson's (Fig. S4B) coefficient analysis indicates that GSK3β overlap with each 352
compartment is specific and non-random. Moreover, the specific recruitment of GSK3β to the 353 limiting membrane of LAMP1-positive late endosomes/lysosomes is supported by images 354 obtained by SIM (Fig. 6D) , as well as by the observation that perturbation of late 355 endosome/lysosome membrane traffic by expression of a dominant interfering mutant of Rab7 356 abolishes the overlap of GSK3β with LAMP1 signals (Fig. S4C) . Our observations are thus 357 consistent with the notion that GSK3β is localized to a number of distinct cellular compartments, 358 with a minor pool that in some cases is <10% of total cellular GSK3β, recruited to each such 359 compartment at steady state. perturbation of APPL1 by silencing did not impact mTORC1-dependent control of GSK3β 367 nuclear localization (Fig. S4D) , suggesting that the APPL1-localized pool of GSK3β does not 368 directly participate in the regulation of GSK3β nuclear localization by mTORC1. 369
As mTORC1 localizes to the surface of late endosomes and lysosomes, the pool of 370
GSK3β on these membranes may be under the direct regulation by mTORC1 to control GSK3β 371 nucleocytoplasmic shuttling. Indeed a previous report had observed some overlap of GSK3β and 372 the lysosome (Li et al., 2016) . However, GSK3β may also be sequestered within intraluminal 373 vesicles of multivesicular bodies in response to Wnt signaling (Taelman et al., 2010), raising the 374 possibility that the overlap that we observed by spinning disc confocal microscopy between 375 LAMP1-positive structures and GSK3β (Fig. 6C) could reflect GSK3β within intraluminal 376 vesicles. However, examination of SIM images suggests that very little, if any, GSK3β is 377 observed within the lumen of LAMP1-positive structures (Fig. 6D) , suggesting that LAMP1-378 localized GSK3β is largely associated with the limiting membrane of these compartments. 379
Moreover, perturbation of Rab7 disrupts the localization of GSK3β and LAMP1 (Fig. S4C) , 2010) . By expression of mutants of Ran (Fig.  405 3), we show that the nucleocytoplasmic shuttling of GSK3β is Ran-dependent. Nuclear import of 406
GSK3β resulting from mTORC1 inhibition by rapamycin was prevented in cells expressing Ran 407 G19V mutant defective in GTP hydrolysis and thus defective in nuclear import. Hence, nuclear 408 import of GSK3β regulated by mTORC1 is Ran-dependent. 409
We examined whether the phosphorylation of S9 on GSK3β could control its mTORC1-410 regulated nuclear localization; however, two observations strongly suggest that this is not the 411 case: (i) inhibition of mTORC1 by rapamycin did not alter S9 phosphorylation of GSK3β (Fig.  412 5A), and (ii) a mutant of GSK3β that cannot be phosphorylated at this position (S9A) behaved 413 similarly to wild-type with respect to mTORC1-dependent nuclear localization (Fig. 5B) . and p38 MAPK, respectively, each of which lead to reduction in GSK3β activity. Notably, using 418 a phos-tag gel electrophoresis approach, a technique that exacerbates the apparent molecular 419 weight increase caused by phosphorylation, we were only able to resolve two bands for GSK3β 420 that likely correspond to S9 phosphorylated and non-S9 phosphorylated forms (Fig. S4A) . It will 421 be interesting to determine in future studies if and how phosphorylation at sites other than S9 are 422 regulated by mTORC1 to control GSK3β nuclear localization. GSK3β nuclear localization when these interactions are present. 440 We also found that Rab7 is required to retain GSK3β in the cytoplasm under conditions 441 when mTORC1 is otherwise active. Importantly, disruption of late endosome/lysosome 442 membrane traffic by perturbations of Rab7 or other proteins does not impact mTORC1 activity 443 (Flinn et al., 2010) . This indicates that the ability of mTORC1 to limit the nuclear localization of 444 GSK3β requires active traffic to the late endosome/lysosome. This in turn suggests that the 445 protein interactions engaged by GSK3β that occlude its NLS and thus limit nuclear localization 446 may occur on the lysosome, consistent with our observed localization of GSK3β to the lysosome. 447 Indeed GSK3α and GSK3β have nearly identical kinase domains (in which the NLS is found), 448 consistent with the ability of mTORC1 to gate nuclear access for both GSK3 paralogs. 449 Furthermore, our observations that mTORC1 controls GSK3β nuclear localization add to 450 previous reports that GSK3β activates mTORC1 signals (Inoki et al., 2006) , and suggests the 451 existence of reciprocal regulation of mTORC1 and GSK3β. Overall, we propose that mTORC1 452 signals limit the ability of GSK3β to localize to the nucleus, and that this may result from 453 mTORC1-dependent control of GSK3β interactions with other proteins in a manner that 454 regulates occlusion of the NLS of GSK3β at the lysosome. by rapamycin is insensitive to impairment of autophagy induction elicited by siRNA gene 475 silencing of ULK1 (Fig. S3) . Moreover, we find that the rapamycin-induced reduction in c-myc 476 levels is countered by perturbation of GSK3β (Fig. 1A-B) . Hence, our results indicate that 477 mTORC1-dependent control of GSK3β nuclear localization regulates c-myc in a manner that 478 does not require induction of autophagy. is possible that differences in metabolism between cancer cells that result in distinct GSK3β 500 nuclear localization profiles may underlie in part the differences in response to drugs targeting 501 GSK3β in cancer, although this remains to be examined. 502
503
In conclusion, we identified that GSK3β nucleocytoplasmic shuttling is controlled by 504 both mitogenic signals such as PI3K-Akt and metabolic cues including amino acid or ATP 505 availability as a result of mTORC1-dependent control of GSK3β nuclear import. In addition, 506
GSK3β localized in part to the late endosome/lysosome and nuclear localization of GSK3β was 507 regulated by Rab7, suggesting that membrane traffic at late endosomes and lysosomes impacts 508 signals leading to control of GSK3β nuclear localization. Lastly, we propose that GSK3β-509 dependent control of nuclear proteins by mTORC1 occurs by regulation of GSK3β nuclear 510 import, linking nutrient availability to control of energy-dependent transcriptional networks. 511 Waltham, MA) containing 10 % fetal bovine serum, 100 U/ml penicillin and 100 μ g/ml 535 streptomycin. Cells were then incubated at 37 C and 5 % CO 2 . MDA-MB-231 cells were 536 obtained from ATCC and cultured as previously described (Fekri et al., 2016) with RPMI media 537 1640 (Gibco) containing 10 % fetal bovine serum, 100 U/ml penicillin and 100 μ g/ml 538 streptomycin and incubated at 37C and 5 % CO 2 . 539
All inhibitor treatments were performed (alone or in combination) for 1 h prior to 540 experimental assays unless otherwise indicated, as follows: 10 Western blotting using whole-cell lysates were performed as previously described (Garay 570 et al., 2015) . Cells were lysed in Laemmli sample buffer (LSB; 0.5 M Tris, pH 6.8, glycerol, 5% 571 bromophenol blue, 10% β-mercaptoethanol, 10% SDS; BioShop, Burlington, ON) containing 572 phosphatase and protease cocktail (1 mM sodium orthovanadate, 10 nM okadaic acid, and 20 nM20 protease inhibitor, all from BioShop, Burlington, ON). Cell Lysates were then heated to 65C for 574 15 min, then passed through with a 27.5-gauge syringe. Proteins within whole-cell lysates were 575 resolved by Glycine-Tris SDS-PAGE and then transferred onto a polyvinylidene fluoride 576 (PVDF) membrane, which was then incubated with a solution containing specific primary 577 antibodies. Western blot signal intensity detection corresponding to either phosphorylated 578 proteins (e.g. pGSK3β S9), total proteins (e.g. GSK3β), and the respective loading controls (e.g. 579 actin) were obtained by signal integration in an area corresponding to the specific lane and band 580 for each condition. The measurement of phosphorylation of a specific protein was obtained by 581 normalization of the signal intensity of a phosphorylated form a protein to that of its loading 582 control signal, then normalization to the signal intensity similarly obtained for the corresponding 583 total protein. 584
To examine phosphorylation of proteins for which no specific antibodies were available, 585
we used the phos-tag gel system, which results in exaggeration of differences in apparent 586 molecular weight of phosphorylated forms of specific proteins (Kinoshita et al., 2006) . The phos-587 tag reagent was obtained from Wako (Osaka, Japan), and was used for conjugation within SDS-588 PAGE polymerization as per the manufacturer's instructions. After SDS-PAGE was completed, 589 gel was submerged in MnCl 2 for chelation of remaining phos-tag moieties. Subsequently, protein 590 intensity detection, measurement, and processing are identical to steps mentioned above. 591 592
Immunofluorescence staining 593 594
Cells grown on glass coverslips were first subjected to fixation using cold methanol, 595 blocked in 5% bovine serum albumin (BioShop), then stained with specific primary antibodies, 596 (Figs. 3B, 4B, 6 , S2, S3A & 659 S4B) were analyzed by student's t-test, with p < 0.05 as a threshold for statistically significant 660 difference between conditions. Measurements of samples involving one experimental parameter 661 and more than two conditions (Figs. 1, 2B, 4A , 4C & S1) were analyzed by one-way ANOVA, 662 followed by Bonferonni post-test to compare differences between conditions, with p < 0.05 as a 663 threshold for statistically significant difference between conditions. Measurements of samples 664 involving two experimental parameters (Figures 3, 5, 7, S3B, S3C, S4C & S4D) were analyzedby two-way ANOVA, followed by Bonferonni post-test to compare differences between 666 conditions, with p < 0.05 as a threshold for statistically significant difference between conditions. 667 
